Treatments & Interventions
Research Evidence
Peer-reviewed studies linked via MeSH term "Giant Cell Tumor of Tendon Sheath" from the MEDLINE/PubMed database.
Sort:
Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
[object Object], [object Object], [object Object] · ANZ J Surg · 2023
PMID: 37052058Meta-Analysis
Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
[object Object], [object Object], [object Object] · Front Immunol · 2022
Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · PLoS One · 2021
Arthroscopic Versus Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies.
[object Object], [object Object], [object Object] et al. · J Am Acad Orthop Surg Glob Res Rev · 2021
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
[object Object], [object Object], [object Object] et al. · Drug Des Devel Ther · 2020
Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease.
[object Object], [object Object], [object Object] · J Am Acad Orthop Surg Glob Res Rev · 2020
Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature.
[object Object], [object Object], [object Object] et al. · Orthop Traumatol Surg Res · 2017
PMID: 28428036Meta-Analysis
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.
[object Object], [object Object], [object Object] et al. · Oncologist · 2025
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
[object Object], [object Object], [object Object] et al. · Lancet · 2024
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
[object Object], [object Object], [object Object] et al. · Clin Orthop Relat Res · 2023
Search all PubMed articles for Fibrous histiocytoma of tendon sheath
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Arthralgias
Very frequent (80-99%)HP:0002829
Abnormality of the knee
Frequent (30-79%)HP:0002815
Arthritis
Frequent (30-79%)HP:0001369
Breakdown of bone
Frequent (30-79%)HP:0002797
Joint hemorrhage
Frequent (30-79%)HP:0005261
Joint swelling
Frequent (30-79%)HP:0001386
Limitation of joint mobility
Frequent (30-79%)HP:0001376
Stiff joint
Frequent (30-79%)HP:0001387
Abnormal temporal bone morphology
Occasional (5-29%)HP:0009911
Abnormal tympanic membrane morphology
Occasional (5-29%)HP:0040090
Abnormality of the ankle
Occasional (5-29%)HP:0003028
Abnormality of the auditory canal
Occasional (5-29%)HP:0000372
Abnormality of the elbow
Occasional (5-29%)HP:0009811
Abnormality of the hip joints
Occasional (5-29%)HP:0001384
Abnormality of the shoulder
Occasional (5-29%)HP:0003043
Abnormality of the wrist
Occasional (5-29%)HP:0003019
Groin pain
Occasional (5-29%)HP:0031520
Hearing loss, conductive
Occasional (5-29%)HP:0000405
Multiple lentigines
Occasional (5-29%)HP:0001003
Onset of lymphedema around puberty
Occasional (5-29%)HP:0001004
Calcium deposits in joints
Very rare (1-4%)HP:0000934
Localized osteoporosis
Very rare (1-4%)HP:0040161
Polyarticular arthropathy
Very rare (1-4%)HP:0005195
Synovial lining hyperplasia
Very rare (1-4%)HP:0005186
Quick Facts
- SNOMED CT
- 310605004
- UMLS CUI
- C1318543
- Fully Specified Name
- Fibrous histiocytoma of tendon sheath (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 24
- Known Treatments
- 1
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.